📰 Psilera Inc News
Psilera Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psilera Inc. Real-time updates on events, politics, business and more.
August 16, 2023
Cybin’s New US Patent Covers Proprietary Deuterated Psychedelic Analogs
December 8, 2022
/PRNewswire/ -- Psilera is proud to be an invited presenter at the Biotech Showcase of 2023 in San Francisco, CA. This prestigious event surrounding the JP...
October 20, 2022
/PRNewswire/ -- The 5th Annual Neuropsychiatric and Psychedelics Drug Development Summit will be held in Boston, MA from October 31st to November 2nd. Dr....
September 14, 2022
/PRNewswire/ -- Psilera Inc. ("Psilera"), a biopharmaceutical company optimizing next-generation mental health treatments, announces the patent approval of...
August 10, 2022
/PRNewswire/ -- Psilera Inc. ("Psilera"), a biopharmaceutical company optimizing next-generation mental health treatments with a technology-enabled platform,...
March 24, 2022
/PRNewswire/ -- Psilera, Inc. ("Psilera") has named Daniel N. Santiago, Ph.D. as the Director and Head of their Computational Chemistry Department. Dr....
March 17, 2022
/PRNewswire/ -- Jacqueline von Salm, Ph.D., Chief Scientific Officer and Co-founder of Psilera Inc., will be interviewed alongside Matthew W. Johnson, Ph.D....
March 8, 2022
TAMPA, Fla., March 8, 2022 /PRNewswire/ -- Psilera Inc. (Psilera), a biotechnology company specializing in the clinical development of psychedel...
March 8, 2022
/PRNewswire/ -- Psilera Inc. ("Psilera"), a biotechnology company specializing in the clinical development of psychedelic-inspired compounds and drug delivery...
March 8, 2022
/PRNewswire/ -- Psilera Inc. ("Psilera"), a biotechnology company specializing in the clinical development of psychedelic-inspired compounds and drug delivery...